Yearly Archives: 2023

/2023

Rolled over price concessions for November 2023 – Updated

The following price concessions granted in October 2023 have rolled over to November 2023: Update (13th November 2023) Following price change mechanism rules Atomoxetine 10mg capsules (28) have been removed from the list of price concessions rolled over into November 2023. The actual reimbursement price for prescriptions submitted as dispensed in November 2023 is £50.11 [...]

The post Rolled over price concessions for November 2023 – Updated appeared first on Community Pharmacy England.

By |November 1st, 2023|Lexpos News|Comments Off on Rolled over price concessions for November 2023 – Updated

Gepretix® added to the HRT PPC medicines list from November 2023

From 1 November 2023, the list of medicines covered by the HRT prepayment certificate (HRT PPC) will be updated to include a new brand of progesterone micronised capsules, Gepretix®. Part XVI of the November 2023 Drug Tariff will be updated to include the following new HRT medicine for which patients will be able to purchase an [...]

The post Gepretix® added to the HRT PPC medicines list from November 2023 appeared first on Community Pharmacy England.

By |November 1st, 2023|Lexpos News|Comments Off on Gepretix® added to the HRT PPC medicines list from November 2023

October 2023 Price Concessions – Final Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/10/2023) announced the following final list of price concessions for October 2023: Drug Pack size Price concession Atomoxetine 10mg capsules 28 £45.59 Amisulpride 200mg tablets 60 £31.19 Betahistine 16mg [...]

The post October 2023 Price Concessions – Final Update appeared first on Community Pharmacy England.

By |October 31st, 2023|Lexpos News|Comments Off on October 2023 Price Concessions – Final Update

MHRA Drug Safety Update: October 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 3 October 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age MedSafetyWeek November 2023: your Yellow Card report helps [...]

The post MHRA Drug Safety Update: October 2023 appeared first on Community Pharmacy England.

By |October 31st, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update: October 2023

#AskYourPharmacistWeek: NPA data highlights public appreciation of Community Pharmacy

Pharmacy Press As today marks the beginning of Ask Your Pharmacist Week (October 30th to November 6th), the National Pharmacy Association (NPA) has also released survey data highlighting that more people in England are embracing community pharmacies as key healthcare settings. This polling data supports the wider efforts to promote the crucial role of pharmacies [...]

The post #AskYourPharmacistWeek: NPA data highlights public appreciation of Community Pharmacy appeared first on Community Pharmacy England.

By |October 30th, 2023|Lexpos News|Comments Off on #AskYourPharmacistWeek: NPA data highlights public appreciation of Community Pharmacy